Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Euthymics Bioscience logo

Euthymics Bioscience

Recent Finacing

Series A ext

Recent Raise

$4M

Euthymics Bioscience is a clinical-stage neuroscience company developing triple reuptake inhibitors—EB-1010 for major depression and EB-1020 as a non-stimulant adult ADHD therapy—based in Cambridge, MA.

Founded 2009
Massachusetts, United States
11-50
Private
euthymics.com

Highlights

Focus Areas

Addiction Treatment
Biotechnology
Life Science
Pharmaceutical

Recent Investors

Venture Investors logo
GBS Venture Partners logo
dRx Capital logo
State of Wisconsin Investment Board logo
Hambrecht & Quist Capital Management logo
H
H
Novartis logo

Financials

$28M

Total Raised

2

Funding rounds

8

Investors